These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27958776)

  • 1. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.
    Colbath AC; Dow SW; Phillips JN; McIlwraith CW; Goodrich LR
    Stem Cells Dev; 2017 Apr; 26(7):503-511. PubMed ID: 27958776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
    Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
    Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells.
    Wada N; Bartold PM; Gronthos S
    Stem Cells Dev; 2011 Apr; 20(4):647-59. PubMed ID: 20712449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
    Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
    Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.
    Carrade Holt DD; Wood JA; Granick JL; Walker NJ; Clark KC; Borjesson DL
    Stem Cells Dev; 2014 Jun; 23(11):1258-65. PubMed ID: 24438346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study.
    Talwadekar MD; Kale VP; Limaye LS
    Sci Rep; 2015 Oct; 5():15784. PubMed ID: 26507009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of T lymphocyte reactivity inhibited by allogeneic bone marrow mesenchymal stem cells].
    Chen JL; Feng K; Guo ZK; U RN; Xu C; Li YH; Liu XD; Mao N; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):740-2. PubMed ID: 16620579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro.
    Kiernan CH; Hoogduijn MJ; Franquesa M; Wolvius EB; Brama PAJ; Farrell E
    Cytotherapy; 2016 Aug; 18(8):957-969. PubMed ID: 27288309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow mesenchymal stem cells derived from patients with myelodysplastic syndrome possess immunosuppressive activity].
    Zhang YZ; DA WM; Huang WR; Gao CJ; Guo B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):302-5. PubMed ID: 17493336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
    Lin W; Oh SK; Choo AB; George AJ
    Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
    Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
    Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.